Last reviewed · How we verify
NCT02174640: COF1
Acute Effects of Coffee Beverage on Postprandial Inflammation and Oxidative Stress - A Pilot Study
NA trial testing Coffee in Overweight in 9 participants. Completed in 16 December 2014.
27 October 2014
Quick facts
| Lead sponsor | Clinical Nutrition Research Center, Illinois Institute of Technology |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | basic science |
| Enrollment | 9 |
| Start date | 15 June 2014 |
| Primary completion | 27 October 2014 |
| Estimated completion | 16 December 2014 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Coffee
- Water (WATER) — full drug profile →
Conditions studied
- Overweight — all drugs for Overweight →
- Obese — all drugs for Obese →
- Healthy — all drugs for Healthy →
Sponsor
Clinical Nutrition Research Center, Illinois Institute of Technology — full company profile →
Who can join
Adults 20 to 45, female only, with Overweight or Obese. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective is to test if acute supplementation with Coffee would improve antioxidant status, following consumption of a pro-oxidative high carbohydrate, high fat meal in over weight/ obese humans. Secondary objective is to determine the ability of coffee to modify postprandial inflammation in overweight/ obese humans.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02174640
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Coffee
Trials testing the same drug.
- NCT07159152 — Effects of Coffee Versus Hibiscus Tea Consumption During Prolonged Sitting on Blood Pressure and Heart Rate · NA · not yet recruiting
- NCT07420699 — The Acute Effects of Specialty Coffee on Cognitive Function in People With Type 2 Diabetes · NA · completed
- NCT06028659 — Investigation of in Vivo Endogenous and/or Exogenous Production of Phenolic Metabolites Using (un)Targeted Metabolomics · NA · recruiting
- NCT07002307 — The Effect of Honey-sweetened Coffee, Black Tea and Green Tea on Some Physiological Parameters · NA · completed
- NCT05709847 — The Effects of Specialty Coffee on Cognitive Function in People With Type 2 Diabetes · NA · unknown
Other recruiting trials for Overweight
Currently open trials in the same condition.
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07472881 — Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women · NA · recruiting
- NCT07465965 — A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults · Phase 1 · recruiting
- NCT07407348 — A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the · Phase 1 · recruiting
- NCT07400653 — A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) · Phase 3 · recruiting
Other Clinical Nutrition Research Center, Illinois Institute of Technology trials
Trials by the same sponsor.
- NCT06986161 — Optimizing Mango's Glycemic Impact: Investigating Mango Consumption Timing in Prediabetic Individuals · NA · recruiting
- NCT06555952 — MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors · NA · recruiting
- NCT05898217 — Vitamin and Mineral Absorption From Milk and PBMAs · NA · active not recruiting
- NCT05892328 — Watermelon Dose Response Blood Pressure Study · NA · active not recruiting
- NCT05601635 — ButyraGen™, Short Chain Fatty Acids and Gut Microbiome · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02174640 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Clinical Nutrition Research Center, Illinois Institute of Technology
- Last refreshed: 28 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02174640.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing